Delivery Order SPE2DB22D2007-SPE2DB25FJ5BX
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/mL ampules, with a contract ceiling value of $2,078.12. The award, issued on August 18, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 19, 2025. Performance will be executed from the company's location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement, indicating the award resulted from open...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of epinephrine injection. This firm fixed-price delivery order, valued at $7,764.88, represents a non-competitive set-aside contract and is scheduled for completion by September 8, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Epinephrine 1 mg/ml ampules. This non-set-aside, competitively awarded contract is valued at $1,699.56 with a firm fixed price and an ultimate completion date of July 22, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Epinephrine 1 mg/mL ampules, valued at $2,807.85. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for ultimate completion by September 4, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order,...
- The Defense Logistics Agency awarded a delivery order valued at $1,122.00 to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/mL ampules. This non-competitive delivery order, issued on August 5, 2025, represents a firm fixed-price purchase under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. As a leading pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order valued at $3,366.00 to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/ml ampules. This firm fixed-price, competitively awarded contract was executed on September 18, 2025, with an ultimate completion date of September 19, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/mL ampules, with a contract ceiling value of $1,800.50. The award, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a firm fixed-price delivery order with no set-aside designation. The performance location is established at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/ml ampules under a firm fixed-price contract valued at $1,191.06. The award was issued on August 4, 2025, with an ultimate completion date of August 5, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a non-competitive award issued under an existing contract vehicle, reflecting the agency's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for epinephrine injection supplies valued at $7,764.88. This firm fixed price delivery order, with an ultimate completion date of September 11, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and fulfills...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,054.16 on July 28, 2025, for the supply of Epinephrine 1 mg/mL ampules. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 29, 2025. The award is funded by the Defense Logistics Agency's Medical Supply Chain, a Defense Department organization...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ5BXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Epinephrine 1 mg/ml ampules with a ceiling value of $2,582.69. This is a firm fixed price delivery order with no set-aside designation, reflecting open competition for the award. The contract is scheduled for ultimate completion on September 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The parent IDC vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including products for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The epinephrine delivery under this order supports the medical supply chain requirements within the broader DLA Pharmaceutical Prime Vendor program, which ensures availability of emergency medications and essential medical commodities across federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 9/18/25 |